5-Fluorouracil and isoprinosine in the treatment of advanced colorectal cancer. A limited phase I, II evaluation. 1988

M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
Division Di Oncologia Medica, Policlinico-Universita' Perugia, Italy.

We studied the effects of 5-fluorouracil (5-FU) and isoprinosine (ISO) on 15 patients with previously untreated metastatic colorectal carcinoma. The patients were treated in a limited Phase I, II protocol. All patients received a fixed ISO dose of 4 g orally on days 1 through 5 of each cycle. Each cycle was repeated every 35 days. The first seven patients were treated with an initial 5-FU dose of 7.5 mg/kg intravenously (IV) on days 1 through 5, which was escalated to 11.5 mg/kg IV after the first course and to 13 mg/kg IV after the second course. The next eight patients were treated with an initial 5-FU dose of 11.5 mg/kg IV on days 1 through 5, which was escalated to 13 mg/kg IV on days 1 through 5. No major responses (complete or partial) were documented. Median survival for all evaluable patients was 33 weeks. Toxicity was predominantly gastrointestinal and hematologic and was considered moderate. Our data suggest that 5-FU and ISO, at the doses used, were ineffectual in the treatment of metastatic colorectal carcinoma.

UI MeSH Term Description Entries
D007542 Inosine Pranobex An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly. Inosiplex,Methisoprinol,Imunovir,Isoprinosin,Isoprinosine,Methysoprinol,Metisoprinol,NPT-10381,NPT 10381,NPT10381,Pranobex, Inosine
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
October 1984, Cancer research,
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
January 1981, Cancer clinical trials,
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
April 1978, Cancer treatment reports,
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
January 1989, Oncology,
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
September 1995, Clinical cancer research : an official journal of the American Association for Cancer Research,
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
May 2002, BMC cancer,
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
January 1992, European journal of cancer (Oxford, England : 1990),
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
December 1989, American journal of clinical oncology,
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
November 1976, Cancer treatment reports,
M Colozza, and M Tonato, and V Belsanti, and A M Mosconi, and S Fiorucci, and I Gernini, and P Rambotti, and S Davis
February 1991, Investigational new drugs,
Copied contents to your clipboard!